Elevating Our Communities With Every Interaction

Velocity is the world's leading integrated site organization.

Sponsors and CROs trust Velocity to deliver high-quality clinical trial data and patient care with unprecedented efficiency.

Simplify everything from site selection to study close-out

Velocity unifies operational processes to provide world-class sites, reliable enrollment, and predictably high performance for your trials.

Research sites across the U.S. and Europe
+
Investigators with diverse experience
+
Clinical trials conducted since 1986
treatment
mother-and-child-2
Hallandale
caring african medical nurse comforting senior patient in office
Velocity-team-office

The right sites.
The right investigators.
The right partner for you.

Strategically located to give you access to diverse specialty populations, Velocity's sites are supported by next-gen technologies and patient engagement capabilities. Welcome to recruitment and retention reimagined.

Supporting research programs worldwide

From the leading pharma companies, to the most pioneering biotech startups, Velocity supports those who are exploring new frontiers in human health.

Whether you’re ready to conduct a single-site study or a complex, high-volume clinical trial, contact Velocity.

News

‘New Era’ for Alzheimer’s Treatments Spur Researcher Optimism

September 21, 2023
‘New Era’ for Alzheimer’s Treatments Spur Researcher Optimism

After battling on the frontline for many years against an aggressive and elusive opponent, Michael Hemphill, MD and the Velocity team in Savannah, GA, believe we’ve entered an exciting “new era” … Read more

Velocity Syracuse Team Advances Important Alzheimer’s Trials 

September 21, 2023
Velocity Syracuse Team Advances Important Alzheimer’s Trials

Alzheimer’s is currently ranked as the seventh leading cause of death in the United States and is the most common cause of dementia among older adults.  Alzheimer’s disease, a cruel … Read more

Velocity Launches Vaccine Council to Accelerate Research Excellence (CARE)

September 14, 2023
Velocity Launches Vaccine Council to Accelerate Research Excellence (CARE)

Velocity has introduced the Vaccine Council to Accelerate Research Excellence (CARE). This council will bring world-class operational, patient recruitment, and trial conduct oversight to all Velocity sites conducting vaccine studies … Read more

Julio Rosenstock, MD Co-Authored an Article Published in NEJM

September 13, 2023
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity

Another positive step in obesity research: Julio Rosenstock, MD, is a co-author of an article now featured on The New England Journal of Medicine homepage, and in the publication’s weekend … Read more

Quality. Continuity. Velocity.